NORTHERN TRUST CORP - ARIAD PHARMACEUTICALS INC ownership

ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 180 filers reported holding ARIAD PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of ARIAD PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$26,045,000
-16.5%
2,093,677
-8.1%
0.01%
-20.0%
Q3 2016$31,203,000
+90.3%
2,279,302
+2.7%
0.01%
+100.0%
Q2 2016$16,401,000
+21.4%
2,219,448
+4.1%
0.01%
+25.0%
Q1 2016$13,510,000
+3.2%
2,133,052
+1.8%
0.00%0.0%
Q4 2015$13,091,000
+8.2%
2,094,590
+1.1%
0.00%0.0%
Q3 2015$12,099,000
-22.4%
2,071,567
+9.8%
0.00%
-20.0%
Q2 2015$15,596,000
-7.4%
1,885,869
-7.7%
0.01%0.0%
Q1 2015$16,834,000
+21.7%
2,042,956
+1.5%
0.01%
+25.0%
Q4 2014$13,827,000
+22.6%
2,012,634
-3.7%
0.00%0.0%
Q3 2014$11,280,000
+79.8%
2,088,998
+112.2%
0.00%
+100.0%
Q2 2014$6,272,000
-21.1%
984,610
-0.2%
0.00%
-33.3%
Q1 2014$7,952,000
+47.3%
986,531
+24.6%
0.00%
+50.0%
Q4 2013$5,399,000
-62.3%
791,706
+1.6%
0.00%
-60.0%
Q3 2013$14,333,000
-1.4%
778,972
-6.3%
0.01%0.0%
Q2 2013$14,536,000831,1200.01%
Other shareholders
ARIAD PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Sarissa Capital Management LP 12,850,000$175,916,00040.51%
Consonance Capital Management LP 8,695,742$119,045,00011.46%
Tamarack Advisers, LP 3,700,000$49,358,0007.76%
Opaleye Management Inc. 1,045,000$14,306,0007.49%
Granite Point Capital Management, L.P. 457,415$6,262,0002.44%
Redmile Group, LLC 2,138,471$29,276,0002.33%
IRONWOOD INVESTMENT MANAGEMENT LLC 206,010$2,820,0002.17%
Palo Alto Investors LP 2,587,617$35,424,0002.06%
PRICE MICHAEL F 940,000$12,869,0001.71%
HighVista Strategies LLC 638,086$8,735,0001.62%
View complete list of ARIAD PHARMACEUTICALS INC shareholders